Patients with diabetic retinopathy should be monitored according to standard diabetes care guidelines, as rapid improvement in glycemic control has been associated with temporary worsening of retinopathy in some studies, though this is not a tirzepatide-specific labeled warning
The gradual titration schedule used in our program is specifically designed to minimize these effects
However, severe swelling, intense pain, warmth, pus, or signs of injection should be reported to a healthcare provider
Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the publics health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke
These skin symptoms may appear shortly after starting the medication or develop after several weeks or months
iScience 27 , 109923 (2024)